[Evaluation of a practical use of synthetic antimalarials in the treatment of rheumatoid polyarthritis].
D000368:Aged; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D000962:Antimalarials; D006886:Hydroxychloroquine; D002738:Chloroquine; D010113:Oxyphenbutazone; D001241:Aspirin; D011241:Prednisone; D007213:Indomethacin
Bilan d'une utilisation pratique des antimalariques de synthèse dans le traitement de la polyarthrite rhumatoide.